Results 251 to 260 of about 1,890,729 (361)

Training in Administrative Procedures of Personnel for Child Health Work

, 1932
John A. Ferrell
openalex   +2 more sources

Variation in Neurodegeneration‐Linked Brain Regions in Young Adult APOE E4 Carriers With Spina Bifida

Annals of the Child Neurology Society, EarlyView.
ABSTRACT Objective Possible pleiotropic effects of apolipoprotein E4 (APOE E4) in individuals with congenital brain malformations are relatively unknown. Our goal was to determine if neurodegeneration‐linked brain region volumes differ significantly between E4 carriers and noncarriers in young adults with spina bifida (SB). Methods Eleven individuals ( 
Joan M. Jasien, Jacques A. Stout, Mohamad A. Mikati, Robert J. Anderson, Brittany G. Nave, Herbert E. Fuchs, Brian Smith, Alexandra Badea, Jeffrey N. Browndyke   +8 more
wiley   +1 more source

The perception of safety regarding the transfer of infants from the neonatal intensive care unit to a level II neonatology department: a mixed-method cohort study using a Safety-II approach. [PDF]

BMC Pediatr
de Bijl-Marcus K, Mossel F, Ahaus K, Pluut B, Benders M, Bruintjes A, Buljac-Samardzic M.   +6 more
europepmc   +1 more source

ADMIRALTY ADMINISTRATION AND PERSONNEL, 1619–1714

Historical Research, 1936
G. F. James, J. J. Sutherland Shaw
openaire   +2 more sources

Recruitment and retention challenges among senior administrative personnel of the University of Cape Coast

, 2006
JT Onyame, Y.A. Ankomah
openalex   +2 more sources

Effect of Mild to Moderate Hepatic Impairment on Valemetostat Pharmacokinetics: An Open‐Label, Phase I Study

Clinical Pharmacology in Drug Development, EarlyView.
Abstract Valemetostat tosylate (valemetostat) is a dual inhibitor of enhancer of zeste homolog (EZH) 2 and EZH1, approved in Japan for the treatment of relapsed/refractory peripheral T‐cell lymphoma and adult T‐cell leukemia/lymphoma. This Phase I, open‐label study evaluated the pharmacokinetics and safety of a single 50‐mg oral dose of valemetostat in
Masaya Tachibana, Thuy Vu Craveiro, Thomas C. Marbury, Samuel Oberstein, George J. Atiee, Ben Tao, Takako Shimizu, Yvonne Lau, Malaz A. Abutarif   +8 more
wiley   +1 more source

Explaining the barriers and facilitators of the accreditation process in maternity departments. [PDF]

BMC Nurs
Hezbiyan Z, Aziz AR, Kadhim AJ, Javadzadeh A, Parizad A, Sedigheh Gil Chalan P, Norouzadeh R, Mehran N, Babaii A, Abbasinia M, Aghaie B.   +10 more
europepmc   +1 more source

A Randomized Thorough QT Trial Using Concentration‐QT Analysis to Evaluate the Effects of Centanafadine on Cardiac Repolarization

Clinical Pharmacology in Drug Development, EarlyView.
Abstract Centanafadine is a norepinephrine/dopamine/serotonin reuptake inhibitor in development for treatment of attention‐deficit/hyperactivity disorder. This double‐blind, placebo‐ and moxifloxacin‐controlled, 3‐period crossover trial evaluated the effects of centanafadine (EB‐1020) and its metabolite (EB‐10601) on cardiac repolarization in 30 ...
Osman S. Turkoglu, Xiaofeng Wang, Jennifer Repella‐Gordon, Susan E. Shoaf   +3 more
wiley   +1 more source

Increasing hospital administrative efficiency via optimized office automation systems: A PDCA cycle approach. [PDF]

PLoS One
Lu R, Zhang Y, Luo L, Yuan Q, Chen S, Lv N, Zheng F, Deng G, Ma Y, Xu J, Chen Z, Zhang F.   +11 more
europepmc   +1 more source

Pharmacokinetics, Bioequivalence, and Safety Studies of Crisaborole Ointment in Healthy Chinese Subjects

Clinical Pharmacology in Drug Development, EarlyView.
Abstract The aim of this study was to evaluate the bioequivalence and safety of a single application of crisaborole ointment to test formulation and reference formulation in healthy subjects under fasting conditions. A total of 32 subjects were included and divided into 2 groups (test‐reference; reference‐test).
Yanchao Wang, Xiaofei Zhao, Taixin Wang, Luning Xiong, Xiujuan Liu, Jing Pan, Wen Yin, Chao Zhang, Jining Dong, Kexin Zhao   +9 more
wiley   +1 more source